Downregulation of NF-κB by Shp-1 Alleviates Cerebral Venous Sinus Thrombosis-Induced Brain Edema Via Suppression of AQP4

J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106570. doi: 10.1016/j.jstrokecerebrovasdis.2022.106570. Epub 2022 May 26.

Abstract

Aquaporin 4 (AQP4), a water channel protein, has been well studied in arterial stroke-induced brain edema. However, the role of AQP4 in cerebral venous sinus thrombosis (CVST) has not been reported. Here, we showed that AQP4 expression was increased in the brain of a rat CVST model, whereas inhibition of AQP4 decreased cerebral edema. Subsequent experiments showed that Shp-1 (Src homology 2-containing phosphatase-1) expression and NF-κB phosphorylation were upregulated after CVST. We found that Shp-1 inhibition resulted in enhancement of NF-κB activation and increased AQP4 expression accompanied by aggravated brain edema. We further showed that NF-κB inhibition led to decreased AQP4 expression and subsequent attenuation of brain edema but had no significant effect on Shp-1 expression. These results provide the first evidence suggesting that downregulation of NF-κB by Shp-1 alleviates CVST-induced brain edema through suppression of AQP4.

Keywords: AQP4; Cerebral venous sinus thrombosis; NF-κB; Shp-1; brain edema.

MeSH terms

  • Animals
  • Aquaporin 4 / metabolism
  • Brain Edema* / drug therapy
  • Brain Edema* / etiology
  • Brain Edema* / prevention & control
  • Down-Regulation
  • NF-kappa B / metabolism
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 / metabolism*
  • Rats
  • Sinus Thrombosis, Intracranial* / drug therapy
  • Sinus Thrombosis, Intracranial* / etiology

Substances

  • Aqp4 protein, rat
  • Aquaporin 4
  • NF-kappa B
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6